These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

717 related items for PubMed ID: 18363989

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs.
    Lautzenhiser SJ, Fialkowski JP, Bjorling D, Rosin E.
    Res Vet Sci; 2001 Jun; 70(3):239-41. PubMed ID: 11676620
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro susceptibilities of feline and canine Escherichia coli and Pseudomonas spp. isolates to ticarcillin and ticarcillin-clavulanic acid.
    Bennett AB, Martin PA, Gottlieb SA, Govendir M.
    Aust Vet J; 2013 May; 91(5):171-8. PubMed ID: 23614511
    [Abstract] [Full Text] [Related]

  • 7. Comparison of pharmacodynamic and pharmacokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats.
    Boothe DM, Boeckh A, Simpson RB, Dubose K.
    J Vet Intern Med; 2006 May; 20(6):1297-306. PubMed ID: 17186841
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fluoroquinolone resistance mechanisms in multidrug-resistant Escherichia coli isolated from extraintestinal infections in dogs.
    Gibson JS, Cobbold RN, Kyaw-Tanner MT, Heisig P, Trott DJ.
    Vet Microbiol; 2010 Nov 20; 146(1-2):161-6. PubMed ID: 20471187
    [Abstract] [Full Text] [Related]

  • 10. In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections.
    Ganière JP, Médaille C, Etoré F.
    Res Vet Sci; 2004 Aug 20; 77(1):67-71. PubMed ID: 15120955
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro potency and efficacy favor later generation fluoroquinolones for treatment of canine and feline Escherichia coli uropathogens in the United States.
    Liu X, Boothe DM, Jin Y, Thungrat K.
    World J Microbiol Biotechnol; 2013 Feb 20; 29(2):347-54. PubMed ID: 23136054
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antimicrobial resistance and pharmacodynamics of canine and feline pathogenic E. coli in the United States.
    Boothe D, Smaha T, Carpenter DM, Shaheen B, Hatchcock T.
    J Am Anim Hosp Assoc; 2012 Feb 20; 48(6):379-89. PubMed ID: 23033458
    [Abstract] [Full Text] [Related]

  • 16. Development of antimicrobial drug resistance in rectal Escherichia coli isolates from dogs hospitalized in an intensive care unit.
    Ogeer-Gyles J, Mathews KA, Sears W, Prescott JF, Weese JS, Boerlin P.
    J Am Vet Med Assoc; 2006 Sep 01; 229(5):694-9. PubMed ID: 16948576
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of catheter-associated urinary tract infections and multi-drug-resistant Escherichia coli isolates from the urine of dogs with indwelling urinary catheters.
    Ogeer-Gyles J, Mathews K, Weese JS, Prescott JF, Boerlin P.
    J Am Vet Med Assoc; 2006 Nov 15; 229(10):1584-90. PubMed ID: 17107313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.